Rainier Acquisition Corporation
Searching since IPO 2026-08-27- CIK 2147219
- RNAQ
- IPO 2026-08-27
- 22 filings
Filings, by quarter
22 filings over 1 quarter; dark bars carry a milestone
- 26 Q3: 22 filings
S-1 filed
IPO
- S-1 filed 26 Q3
- IPO 26 Q3
SPAC Overview
$75M
IPO Size
IPO
Current Status
2026
IPO Year
Timeline Progress
About
Rainier Acquisition Corporation is a blank-check company seeking a business combination, with a primary focus on global life sciences companies applying biology to improve human health, including therapeutics, diagnostics, genomics, precision medicine, life science tools, research services and biomanufacturing.
Investment Focus
Biopharmaceuticals, Healthcare
Key Information
IPO Date
2026-08-27
Jurisdiction of Incorporation
Cayman Islands
SIC
6770
SPAC Ticker
RNAQ
Stock Performance
RNAQU
Trading Symbol
First Trade
2026-08-27
$10.02
Current Price
2026-10-01
$10.06
+0%
SPAC Team
Underwriters
Extended Team Information
The team brings decades of life sciences investing, financing, operating and advisory experience, including public-company leadership and governance, capital markets, M&A and prior SPAC transactions. Its members include Gbola Amusa, Isaac Manke, Jonas Grossman, Andrew Lam and Guy Barudin.